HighTide Therapeutics HK$194.1 million IPO
We advised HighTide Therapeutics on its IPO and HKEX listing
Experience
To find Davis Polk deals and cases of particular interest, select filters based on practice, industry, region, lawyer and keyword.
Filters
Zhejiang Expressway $860 million rights issue
The H shares are listed on the Hong Kong Stock Exchange
Atour Lifestyle Holdings $174.4 million secondary offering
We advised Atour on a secondary offering of ADSs
Weibo concurrent $330 million convertible notes and $63.5 million ADS offerings
The company also entered into an ADS lending agreement in connection with the ADS offering
Kokusai Electric ¥124.5 billion IPO
The deal is the largest Japanese IPO since 2018
Banco Santander $2.5 billion Tier 1 capital securities offering
We advised Banco Santander on its SEC-registered offering of contingent convertible securities
WuXi XDC Cayman HK$3.68 billion IPO
The shares are listed on the HKEX
BBVA $750 million subordinated notes offering
We advised BBVA on its offering of Tier 2 subordinated fixed-to-fixed-rate notes
Banco Santander renewal of $25 billion U.S. commercial paper program
We advised Banco Santander on its program renewal
Sibanye-Stillwater $211.5 million acquisition of Reldan
We are advising Sibanye-Stillwater on the acquisition